143 related articles for article (PubMed ID: 28231675)
21. Effects of prognostic factors and treatment on survival in advanced non-small cell lung cancer.
Cağlayan B; Fidan A; Salepçi B; Kiral N; Torun E; Salepçi T; Mayadağli A
Tuberk Toraks; 2004; 52(4):323-32. PubMed ID: 15558354
[TBL] [Abstract][Full Text] [Related]
22. [Expression of MiRNA-221 in non-small cell lung cancer tissues and correlation with prognosis].
Lv J; Xu L; Xu Y; Qiu M; Yang X; Wang J; Yin R; Xu L
Zhongguo Fei Ai Za Zhi; 2014 Mar; 17(3):221-5. PubMed ID: 24667259
[TBL] [Abstract][Full Text] [Related]
23. Clinical and prognostic significance of OPN and VEGF expression in patients with non-small-cell lung cancer.
Lin Q; Guo L; Lin G; Chen Z; Chen T; Lin J; Zhang B; Gu X
Cancer Epidemiol; 2015 Aug; 39(4):539-44. PubMed ID: 26123318
[TBL] [Abstract][Full Text] [Related]
24. Down-regulation of miR-503 expression predicate advanced mythological features and poor prognosis in patients with NSCLC.
Liu L; Qu W; Zhong Z
Int J Clin Exp Pathol; 2015; 8(5):5609-13. PubMed ID: 26191272
[TBL] [Abstract][Full Text] [Related]
25. Investigation of serum miR-411 as a diagnosis and prognosis biomarker for non-small cell lung cancer.
Wang SY; Li Y; Jiang YS; Li RZ
Eur Rev Med Pharmacol Sci; 2017 Sep; 21(18):4092-4097. PubMed ID: 29028091
[TBL] [Abstract][Full Text] [Related]
26. Risk factor analysis of locoregional recurrence after sublobar resection in patients with clinical stage IA non-small cell lung cancer.
Koike T; Koike T; Yoshiya K; Tsuchida M; Toyabe S
J Thorac Cardiovasc Surg; 2013 Aug; 146(2):372-8. PubMed ID: 23870323
[TBL] [Abstract][Full Text] [Related]
27. Exploring Stage I non-small-cell lung cancer: development of a prognostic model predicting 5-year survival after surgical resection†.
Guerrera F; Errico L; Evangelista A; Filosso PL; Ruffini E; Lisi E; Bora G; Asteggiano E; Olivetti S; Lausi P; Ardissone F; Oliaro A
Eur J Cardiothorac Surg; 2015 Jun; 47(6):1037-43. PubMed ID: 25391390
[TBL] [Abstract][Full Text] [Related]
28. Prognostic impact of malignant pleural effusion at presentation in patients with metastatic non-small-cell lung cancer.
Morgensztern D; Waqar S; Subramanian J; Trinkaus K; Govindan R
J Thorac Oncol; 2012 Oct; 7(10):1485-9. PubMed ID: 22982649
[TBL] [Abstract][Full Text] [Related]
29. Prognostic factors and nomogram for cancer-specific death in non small cell lung cancer with malignant pericardial effusion.
Hu ZG; Hu K; Li WX; Zeng FJ
PLoS One; 2019; 14(5):e0217007. PubMed ID: 31095610
[TBL] [Abstract][Full Text] [Related]
30. Decreased expression of FOXF2 as new predictor of poor prognosis in stage I non-small cell lung cancer.
Kong PZ; Li GM; Tian Y; Song B; Shi R
Oncotarget; 2016 Aug; 7(34):55601-55610. PubMed ID: 27487137
[TBL] [Abstract][Full Text] [Related]
31. Assessing the prognostic impact of the International Association for the Study of Lung Cancer proposed definitions of complete, uncertain, and incomplete resection in non-small cell lung cancer surgery.
Gagliasso M; Migliaretti G; Ardissone F
Lung Cancer; 2017 Sep; 111():124-130. PubMed ID: 28838382
[TBL] [Abstract][Full Text] [Related]
32. High levels of phosphatase and tensin homolog expression predict favorable prognosis in patients with non-small cell lung cancer.
Li XB; Yang Y; Zhang HQ; Yue WT; Zhang TM; Lu BH; Li J; Liu Z; Wang QH; Gao Y; Hu AM; Zhang HM; Shi HL; Hu FB; Li BL
Eur Rev Med Pharmacol Sci; 2015 Jun; 19(12):2231-9. PubMed ID: 26166648
[TBL] [Abstract][Full Text] [Related]
33. The Frequency and Prognostic Impact of Pathological Microscopic Vascular Invasion According to Tumor Size in Non-Small Cell Lung Cancer.
Shimada Y; Saji H; Kato Y; Kudo Y; Maeda J; Yoshida K; Hagiwara M; Matsubayashi J; Kakihana M; Kajiwara N; Ohira T; Ikeda N
Chest; 2016 Mar; 149(3):775-85. PubMed ID: 26379115
[TBL] [Abstract][Full Text] [Related]
34. Survival and prognostic factors of non-small cell lung cancer patients with postoperative locoregional recurrence treated with radical radiotherapy.
Ma L; Qiu B; Zhang J; Li QW; Wang B; Zhang XH; Qiang MY; Chen ZL; Guo SP; Liu H
Chin J Cancer; 2017 Dec; 36(1):93. PubMed ID: 29228994
[TBL] [Abstract][Full Text] [Related]
35. [Survival Analysis of 121 Stage N2-IIIa Non-small Cell Lung Cancer Patients
Treated with Surgery].
Yang H; Dai L; Li P; Shen L; Yan W; Fan M; Chen K
Zhongguo Fei Ai Za Zhi; 2015 Aug; 18(8):505-11. PubMed ID: 26302348
[TBL] [Abstract][Full Text] [Related]
36. Prognostic significance of visceral pleural involvement in early-stage lung cancer.
Lakha S; Gomez JE; Flores RM; Wisnivesky JP
Chest; 2014 Dec; 146(6):1619-1626. PubMed ID: 25032521
[TBL] [Abstract][Full Text] [Related]
37. Prognostic significance of STAT3 expression and its correlation with chemoresistance of non-small cell lung cancer cells.
Yin Z; Zhang Y; Li Y; Lv T; Liu J; Wang X
Acta Histochem; 2012 Feb; 114(2):151-8. PubMed ID: 21549414
[TBL] [Abstract][Full Text] [Related]
38. Gender differences in non-small-cell lung cancer survival: an analysis of 4,618 patients diagnosed between 1997 and 2002.
Visbal AL; Williams BA; Nichols FC; Marks RS; Jett JR; Aubry MC; Edell ES; Wampfler JA; Molina JR; Yang P
Ann Thorac Surg; 2004 Jul; 78(1):209-15; discussion 215. PubMed ID: 15223430
[TBL] [Abstract][Full Text] [Related]
39. Predictive impact for postoperative recurrence using the preoperative prognostic nutritional index in pathological stage I non-small cell lung cancer.
Shoji F; Morodomi Y; Akamine T; Takamori S; Katsura M; Takada K; Suzuki Y; Fujishita T; Okamoto T; Maehara Y
Lung Cancer; 2016 Aug; 98():15-21. PubMed ID: 27393501
[TBL] [Abstract][Full Text] [Related]
40. The International Association for the Study of Lung Cancer Staging Project: prognostic factors and pathologic TNM stage in surgically managed non-small cell lung cancer.
Chansky K; Sculier JP; Crowley JJ; Giroux D; Van Meerbeeck J; Goldstraw P;
J Thorac Oncol; 2009 Jul; 4(7):792-801. PubMed ID: 19458556
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
